Cargando…

HEPATITIS B VACCINATION COVERAGE AND POSTVACCINATION SEROLOGIC TESTING AMONG MEDICAL STUDENTS AT A PUBLIC UNIVERSITY IN BRAZIL

The aim of this cross-sectional study was to determine the hepatitis B vaccination coverage among medical students at a public university in Rio de Janeiro, Brazil, and their compliance with the postvaccination serologic testing recommendations. Of the total of 858 students, 675 (78.7%) participated...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Souza, Eduardo Pernambuco, Teixeira, Marcelo de Souza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto de Medicina Tropical 2014
Materias:	Hepatitis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131816/ https://www.ncbi.nlm.nih.gov/pubmed/25076431 http://dx.doi.org/10.1590/S0036-46652014000400007

Ejemplares similares

High hepatitis B vaccination coverage among a cohort of predominantly men who have sex with men in Germany
por: Esber, Allahna L., et al.
Publicado: (2023)

Durability of serologic responses to inactivated hepatitis A virus vaccination among people living with HIV following acute hepatitis A outbreak: a 5-year follow-up study
por: Lin, Kuan-Yin, et al.
Publicado: (2023)

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study
por: Tang, Zi-Min, et al.
Publicado: (2022)

TEMPORAL TRENDS IN THE DETECTION RATES OF HEPATITIS B IN THE SANTA CATARINA STATE, BRAZIL
por: Marcon, Chaiana Esmeraldino Mendes, et al.
Publicado: (2014)

Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction
por: Wang, Xiaoli, et al.
Publicado: (2023)

HIV AND HCV COINFECTION: PREVALENCE, ASSOCIATED FACTORS AND GENOTYPE CHARACTERIZATION IN THE MIDWEST REGION OF BRAZIL
por: Freitas, Solange Zacalusni, et al.
Publicado: (2014)

Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial
por: Zhong, Guohua, et al.
Publicado: (2023)

Hepatitis C microelimination among people living with HIV in Taiwan
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
por: Wang, Shao-Juan, et al.
Publicado: (2021)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
por: Piermatteo, Lorenzo, et al.
Publicado: (2023)

Role of S protein transmembrane domain mutations in the development of occult hepatitis B virus infection
por: Jiang, Xinyi, et al.
Publicado: (2022)

A standardized assay for the quantitative detection of serum HBV RNA in chronic hepatitis B patients
por: Yu, Guangxin, et al.
Publicado: (2022)

Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy
por: Li, Ning, et al.
Publicado: (2022)

Prevalence of antibody to hepatitis B surface antigen among qualified blood donors in Nanjing, China
por: Zhou, Yi-Hua, et al.
Publicado: (2023)

Molecular epidemiology and genotype-specific disease severity of hepatitis E virus infections in Germany, 2010–2019
por: Schemmerer, Mathias, et al.
Publicado: (2022)

Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testing
por: Stahl, Yannick, et al.
Publicado: (2023)

Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection
por: Wang, Mingjie, et al.
Publicado: (2021)

Knowledge and awareness of viral hepatitis and influencing factors among the general population aged 15–69 years in Zhejiang Province, China
por: Zhou, Yang, et al.
Publicado: (2023)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
por: Yin, Shengxia, et al.
Publicado: (2023)

Hepatitis B virus promotes its own replication by enhancing RAB5A-mediated dual activation of endosomal and autophagic vesicle pathways
por: Zhao, Zhenyu, et al.
Publicado: (2023)

Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma
por: Fu, Ya, et al.
Publicado: (2022)

Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control
por: Yan, Bingyu, et al.
Publicado: (2023)

The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
por: Jiang, Shaowen, et al.
Publicado: (2023)

Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines
por: Li, Fahong, et al.
Publicado: (2022)

HCV INFECTION THROUGH PERFORATING AND CUTTING MATERIAL AMONG CANDIDATES FOR BLOOD DONATION IN BELÉM, BRAZILIAN AMAZON
por: Valois, Rubenilson Caldas, et al.
Publicado: (2014)

Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non‐responders: Double‐blinded, randomised, controlled phase 2 trial
por: Koc, Özgür M., et al.
Publicado: (2021)

Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans
por: Kelly, Christabel, et al.
Publicado: (2016)

Endemicity change of hepatitis A infection necessitates vaccination in food handlers: An Indian perspective
por: Shenoy, Bhaskar, et al.
Publicado: (2021)

“Titer of anti-HBs in health professions trainees: prevalence of antibody coverage in a University of Central Italy”
por: Di Giampaolo, Luca, et al.
Publicado: (2021)

Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine‐induced neutralizing activity
por: Kachko, Alla, et al.
Publicado: (2015)

CRISPR/Cas13a-assisted rapid and portable HBV DNA detection for low-level viremia patients
por: Tian, Yuan, et al.
Publicado: (2023)

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2)
por: Lawitz, Eric, et al.
Publicado: (2016)

Spatial epidemiology of hepatitis C virus infection in Egypt: Analyses and implications
por: Cuadros, Diego F, et al.
Publicado: (2014)

Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt
por: Benova, Lenka, et al.
Publicado: (2015)

Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles
por: Oliveira, Catarina, et al.
Publicado: (2017)

Hepatitis E virus and fulminant hepatitis–a virus or host-specific pathology?
por: Smith, Donald B, et al.
Publicado: (2015)

La hepatitis A aguda
por: Maier, Klaus-Peter
Publicado: (1994)

Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus
por: van de Ven, Nikolien, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jrgjdj9q3dv0gr5ai4drs0ebs6